TrialThe Journal of infectious diseases2025

Azithromycin as Host-Directed Therapy for Pulmonary Tuberculosis: A Randomized Pilot Trial.

Bart G J Dekkers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.